Sarepta Therapeutics Inc (SRPT)
124.25
+7.13
(+6.09%)
USD |
NASDAQ |
Apr 24, 16:00
124.25
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Market Cap: 11.66B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 11.66B |
| April 23, 2024 | 10.99B |
| April 22, 2024 | 10.98B |
| April 19, 2024 | 10.85B |
| April 18, 2024 | 10.94B |
| April 17, 2024 | 11.06B |
| April 16, 2024 | 11.01B |
| April 15, 2024 | 11.10B |
| April 12, 2024 | 11.53B |
| April 11, 2024 | 11.68B |
| April 10, 2024 | 11.85B |
| April 09, 2024 | 11.92B |
| April 08, 2024 | 11.86B |
| April 05, 2024 | 11.83B |
| April 04, 2024 | 11.81B |
| April 03, 2024 | 11.91B |
| April 02, 2024 | 11.92B |
| April 01, 2024 | 12.05B |
| March 28, 2024 | 12.15B |
| March 27, 2024 | 12.22B |
| March 26, 2024 | 12.04B |
| March 25, 2024 | 12.01B |
| March 22, 2024 | 11.97B |
| March 21, 2024 | 11.73B |
| March 20, 2024 | 11.83B |
| Date | Value |
|---|---|
| March 19, 2024 | 11.64B |
| March 18, 2024 | 11.64B |
| March 15, 2024 | 11.55B |
| March 14, 2024 | 11.62B |
| March 13, 2024 | 11.45B |
| March 12, 2024 | 11.45B |
| March 11, 2024 | 11.41B |
| March 08, 2024 | 11.67B |
| March 07, 2024 | 11.34B |
| March 06, 2024 | 11.29B |
| March 05, 2024 | 11.53B |
| March 04, 2024 | 11.63B |
| March 01, 2024 | 12.08B |
| February 29, 2024 | 12.00B |
| February 28, 2024 | 12.91B |
| February 27, 2024 | 13.28B |
| February 26, 2024 | 12.92B |
| February 23, 2024 | 12.81B |
| February 22, 2024 | 12.63B |
| February 21, 2024 | 12.40B |
| February 20, 2024 | 12.76B |
| February 16, 2024 | 12.62B |
| February 15, 2024 | 11.71B |
| February 14, 2024 | 11.65B |
| February 13, 2024 | 11.64B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.266B
Minimum
Jul 19 2021
14.64B
Maximum
May 15 2023
9.125B
Average
9.289B
Median
Aug 16 2019
Market Cap Benchmarks
| PTC Therapeutics Inc | 1.931B |
| Vertex Pharmaceuticals Inc | 103.52B |
| Regenxbio Inc | 785.84M |
| CytomX Therapeutics Inc | 110.39M |
| Apellis Pharmaceuticals Inc | 6.021B |
Market Cap Related Metrics
| PS Ratio | 9.233 |
| Price to Book Value | 13.57 |
| Price | 124.25 |
| Earnings Yield | -4.69% |